Prognostic Value of Soluble Tumor Necrosis Factor Receptors 1 and 2 in Multiple Sclerosis Patients Treated with Interferon Beta-1b

Publisher： Karger

E-ISSN： 1421-9913|46|4|210-214

ISSN： 0014-3022

Source： European Neurology, Vol.46, Iss.4, 2001-11, pp. : 210-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Interferon-beta-1b on Cognitive Functions in Multiple Sclerosis

By  

European Neurology, Vol. 47, Iss. 1, 2002-01 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Arthritis and bursitis in multiple sclerosis patients treated with interferon‐beta

By Strueby L.   Nair B.   Kirk A.   Taylor R. M.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 6, 2005-11 ,pp. : 485-488

Informa Healthcare

Access to resources Recommend Favorite

REGULATION OF HUMAN LUNG FIBROBLAST C1Q-RECEPTORS BY TRANSFORMING GROWTH FACTOR-beta AND TUMOR NECROSIS FACTOR-alpha

By Lurton John   Soto Hortensia   Narayanan A. Sampath   Raghu Ganesh  

Experimental Lung Research, Vol. 25, Iss. 2, 1999-03 ,pp. : 151-164

Informa Healthcare

Access to resources Recommend Favorite

Electrophysiological, Neuropsychological and Clinical Findings in Multiple Sclerosis Patients Receiving Interferon β-1b: A 1-Year Follow-Up

By  

European Neurology, Vol. 44, Iss. 4, 2000-11 ,pp. : 205-209

Karger

Access to resources Recommend Favorite

Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in Iran

By  

European Neurology, Vol. 52, Iss. 4, 2004-12 ,pp. : 202-206

Karger

Access to resources Recommend Favorite